Avalo Therapeutics (AVTX) Short Interest Ratio & Short Volume

$13.32
+1.11 (+9.09%)
(As of 02:16 PM ET)

Avalo Therapeutics Short Interest Data

Current Short Volume
78,500 shares
Previous Short Volume
67,200 shares
Change Vs. Previous Month
+16.82%
Dollar Volume Sold Short
$1.71 million
Short Interest Ratio / Days to Cover
0.1
Last Record Date
March 31, 2024
Outstanding Shares
1,030,000 shares
Percentage of Shares Shorted
7.62%
Today's Trading Volume
55,247 shares
Average Trading Volume
554,452 shares
Today's Volume Vs. Average
10%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Avalo Therapeutics ?

Sign up to receive the latest short interest report for Avalo Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

AVTX Short Interest Over Time

AVTX Days to Cover Over Time

AVTX Percentage of Float Shorted Over Time

Avalo Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202478,500 shares $1.71 million +16.8%N/A0.1 $21.75
3/15/202467,200 shares $293,664.00 +10.3%N/A1.3 $4.37
2/29/202460,900 shares $268,569.00 -4.8%N/A0.7 $4.41
2/15/202464,000 shares $304,640.00 -21.3%N/A0.7 $4.76
1/31/202481,300 shares $378,045.00 -4.0%N/A0.8 $4.65
1/15/202484,700 shares $484,484.00 +32.1%N/A0.7 $5.72
12/31/202364,100 shares $583,310.00 -99.5%N/A0.4 $9.10
12/15/202312,640,000 shares $758,400.00 +23.8%N/A0.2 $0.06
11/30/202310,210,000 shares $713,679.00 -43.7%N/A0.1 $0.07
11/15/202318,140,000 shares $1.79 million +40.8%N/A0.2 $0.10
10/31/202312,880,000 shares $1.41 million +3.5%N/A0.2 $0.11
10/15/202312,450,000 shares $1.85 million -29.1%N/A0.2 $0.15
9/30/202317,550,000 shares $2.12 million +471.7%90.2%0.3 $0.12
9/15/20233,070,000 shares $406,775.00 +220.1%15.8%0.1 $0.13
8/31/2023959,000 shares $95,900.00 +0.2%5.2%0.1 $0.10
8/15/2023957,300 shares $134,022.00 -10.5%5.2%0.2 $0.14
7/31/20231,070,000 shares $214,000.00 +20.6%5.8%0.6 $0.20
7/15/2023887,000 shares $294,572.70 +41.2%7.4%0.7 $0.33
6/30/2023628,400 shares $223,207.68 +1,528.0%5.3%0.6 $0.36
6/15/202338,600 shares $145,329.00 -9.4%0.4%0.1 $3.77
5/31/202342,600 shares $122,262.00 -2.7%0.4%0.6 $2.87
5/15/202343,800 shares $120,450.00 +17.1%0.4%0.9 $2.75
4/30/202337,400 shares $108,834.00 -23.8%0.3%1.2 $2.91
4/15/202349,100 shares $127,660.00 +172.8%0.4%1.7 $2.60
3/31/202318,000 shares $31,500.00 -3.7%0.2%0.7 $1.75
3/15/202318,700 shares $46,843.50 -24.6%0.2%1.1 $2.51
2/28/202324,800 shares $62,496.00 +30.5%0.4%1.6 $2.52
2/15/202319,000 shares $56,240.00 -32.4%0.3%1.3 $2.96
1/31/202328,100 shares $110,714.00 -30.8%0.3%1.7 $3.94
1/15/202340,600 shares $197,316.00 +17.0%0.5%2.7 $4.86
12/30/202234,700 shares $174,891.47 -15.0%0.4%2.4 $5.04
12/15/202240,800 shares $237,864.00 +9.4%0.5%3 $5.83
11/30/202237,300 shares $204,031.00 +9.1%0.4%2.3 $5.47
11/15/202234,200 shares $198,360.00 -3.1%0.4%1.7 $5.80
10/31/202235,300 shares $211,800.00 -27.5%0.4%1.1 $6.00
10/15/202248,700 shares $258,110.00 +10.9%0.6%1.4 $5.30
9/30/202243,900 shares $145,748.00 -34.1%0.5%1.2 $3.32
9/15/202266,600 shares $279,054.00 +26.1%0.8%1.3 $4.19
8/31/202252,800 shares $250,800.00 -39.5%0.6%1 $4.75
8/15/202287,300 shares $467,928.00 -10.9%1.0%1.6 $5.36
This Apple-like Innovator is Revolutionizing Healthcare (Ad)

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry

AVTX Short Interest - Frequently Asked Questions

What is Avalo Therapeutics' current short interest?

Short interest is the volume of Avalo Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 78,500 shares of AVTX short. Learn More on Avalo Therapeutics' current short interest.

Which institutional investors are shorting Avalo Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Avalo Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Avalo Therapeutics' short interest increasing or decreasing?

Avalo Therapeutics saw a increase in short interest in March. As of March 31st, there was short interest totaling 78,500 shares, an increase of 16.8% from the previous total of 67,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Avalo Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Avalo Therapeutics: Aytu BioPharma, Inc. (6.73%), Pieris Pharmaceuticals, Inc. (0.14%), NeuroBo Pharmaceuticals, Inc. (1.93%), Orgenesis Inc. (0.87%), Talphera, Inc. (0.70%), Minerva Neurosciences, Inc. (0.74%), Cocrystal Pharma, Inc. (0.07%), VBI Vaccines Inc. (1.30%), Galecto, Inc. (0.16%), Kiora Pharmaceuticals, Inc. (0.71%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Avalo Therapeutics stock?

Short selling AVTX is an investing strategy that aims to generate trading profit from Avalo Therapeutics as its price is falling. AVTX shares are trading up $0.85 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Avalo Therapeutics?

A short squeeze for Avalo Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AVTX, which in turn drives the price of the stock up even further.

How often is Avalo Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVTX, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:AVTX) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners